Featured Research

from universities, journals, and other organizations

Comic relief for stressed emergency teams

Date:
September 12, 2012
Source:
London School of Hygiene & Tropical Medicine (LSHTM)
Summary:
Researchers in the UK have created a comic influenced by the Japanese manga style to help busy medical staff who treat patients suffering from bleeding.

Cover image of TXA comic.
Credit: Image courtesy of London School of Hygiene & Tropical Medicine (LSHTM)

Researchers at the London School of Hygiene & Tropical Medicine have created a comic influenced by the Japanese manga style to help busy medical staff who treat patients suffering from bleeding.

Professor Ian Roberts devised a storyline to highlight the latest research into the life-saving benefits of tranexamic acid (TXA) in a way which he hopes will appeal to doctors, nurses and paramedics on the front-line of medicine.

The comic by professional artist Emma Vieceli and colourist Paul Duffield sets the scene in a busy emergency department as staff rush to treat people following two explosions.

As well as referencing established facts such as the importance of administering TXA within three hours of injury, the cartoon heroes also flag up new findings published on bmj.com which show that the drug can benefit a wide range of patients and should not be restricted to the most severe cases.

Amid the drama, doctors treating a patient say: "We have to do something about that bleeding. Get me an IV line and one gram of tranexamic acid now."

Prof Roberts said: "Health professionals are inundated with information and treatment guidelines so it can be difficult to keep track of all the latest developments. Our research has demonstrated how lives can be saved by this cheap and effective drug and the new paper shows that it can benefit all levels of severity if given within three hours of injury. We want to make sure that message comes through loud and clear and we hope this comic will get people interested and talking about TXA."

Cambridge-based Emma Vieceli, who is inspired by a fusion of many different styles of comic, said: "I am delighted to have been able to work on this project. It was an unusual challenge for me as I don't often get asked to illustrate medical themes. I hope people enjoy reading it and that patients benefit."

TXA, which was invented in Japan in the 1960s, helps reduce clot breakdown and is given to women as a treatment for heavy periods.

The potential for helping trauma patients was studied by Prof Roberts and an international team of collaborators in the CRASH-2 trial and is also currently being trialled in women at risk of haemorrhage in childbirth through the WOMAN trial.

Before making his foray into "graphic medicine," Prof Roberts experimented with another creative method of making an impact. Last year he produced an animation called TRAN-MAN to help spread the word around the world about the results of CRASH-2, which showed that TXA could prevent thousands of accident victims from bleeding to death.

Link to cartoon: http://blogs.lshtm.ac.uk/news/2012/09/11/tranexamic-acid-manga-offers-comic-relief-for-medics/


Story Source:

The above story is based on materials provided by London School of Hygiene & Tropical Medicine (LSHTM). Note: Materials may be edited for content and length.


Journal Reference:

  1. I. Roberts, P. Perel, D. Prieto-Merino, H. Shakur, T. Coats, B. J. Hunt, F. Lecky, K. Brohi, K. Willett. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. BMJ, 2012; 345 (sep11 1): e5839 DOI: 10.1136/bmj.e5839

Cite This Page:

London School of Hygiene & Tropical Medicine (LSHTM). "Comic relief for stressed emergency teams." ScienceDaily. ScienceDaily, 12 September 2012. <www.sciencedaily.com/releases/2012/09/120911200155.htm>.
London School of Hygiene & Tropical Medicine (LSHTM). (2012, September 12). Comic relief for stressed emergency teams. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/09/120911200155.htm
London School of Hygiene & Tropical Medicine (LSHTM). "Comic relief for stressed emergency teams." ScienceDaily. www.sciencedaily.com/releases/2012/09/120911200155.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

More Coverage


Hundreds More Bleeding Trauma Patients Could Be Saved If Tranexamic Acid Was Used More Widely, Study Suggests

Sep. 11, 2012 The clot stabilizer drug tranexamic acid can be administered safely to a wide range of patients with traumatic bleeding and should not be restricted to the most severe cases, a new study ... read more
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins